Literature DB >> 28069935

Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness.

Shilpa S Iyer1,2, Frederic Bibollet-Ruche1, Scott Sherrill-Mix2, Gerald H Learn1, Lindsey Plenderleith3, Andrew G Smith1, Hannah J Barbian1,2, Ronnie M Russell1,2, Marcos V P Gondim1, Catherine Y Bahari1, Christiana M Shaw1, Yingying Li1, Timothy Decker1, Barton F Haynes4,5,6, George M Shaw1,2, Paul M Sharp3, Persephone Borrow7, Beatrice H Hahn8,2.   

Abstract

Sexual transmission of HIV-1 is an inefficient process, with only one or few variants of the donor quasispecies establishing the new infection. A critical, and as yet unresolved, question is whether the mucosal bottleneck selects for viruses with increased transmission fitness. Here, we characterized 300 limiting dilution-derived virus isolates from the plasma, and in some instances genital secretions, of eight HIV-1 donor and recipient pairs. Although there were no differences in the amount of virion-associated envelope glycoprotein, recipient isolates were on average threefold more infectious (P = 0.0001), replicated to 1.4-fold higher titers (P = 0.004), were released from infected cells 4.2-fold more efficiently (P < 0.00001), and were significantly more resistant to type I IFNs than the corresponding donor isolates. Remarkably, transmitted viruses exhibited 7.8-fold higher IFNα2 (P < 0.00001) and 39-fold higher IFNβ (P < 0.00001) half-maximal inhibitory concentrations (IC50) than did donor isolates, and their odds of replicating in CD4+ T cells at the highest IFNα2 and IFNβ doses were 35-fold (P < 0.00001) and 250-fold (P < 0.00001) greater, respectively. Interestingly, pretreatment of CD4+ T cells with IFNβ, but not IFNα2, selected donor plasma isolates that exhibited a transmitted virus-like phenotype, and such viruses were also detected in the donor genital tract. These data indicate that transmitted viruses are phenotypically distinct, and that increased IFN resistance represents their most distinguishing property. Thus, the mucosal bottleneck selects for viruses that are able to replicate and spread efficiently in the face of a potent innate immune response.

Entities:  

Keywords:  HIV-1 transmission fitness; HIV-1 transmission pairs; innate immunity; mucosal HIV-1 transmission; type I interferons

Mesh:

Substances:

Year:  2017        PMID: 28069935      PMCID: PMC5278458          DOI: 10.1073/pnas.1620144114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  85 in total

1.  Role of interferon-stimulated gene ISG-15 in the interferon-omega-mediated inhibition of human immunodeficiency virus replication.

Authors:  M S Künzi; P M Pitha
Journal:  J Interferon Cytokine Res       Date:  1996-11       Impact factor: 2.607

2.  Role of donor genital tract HIV-1 diversity in the transmission bottleneck.

Authors:  Debrah I Boeras; Peter T Hraber; Mackenzie Hurlston; Tammy Evans-Strickfaden; Tanmoy Bhattacharya; Elena E Giorgi; Joseph Mulenga; Etienne Karita; Bette T Korber; Susan Allen; Clyde E Hart; Cynthia A Derdeyn; Eric Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

3.  Wide variation in the multiplicity of HIV-1 infection among injection drug users.

Authors:  Katharine J Bar; Hui Li; Annie Chamberland; Cecile Tremblay; Jean Pierre Routy; Truman Grayson; Chuanxi Sun; Shuyi Wang; Gerald H Learn; Charity J Morgan; Joseph E Schumacher; Barton F Haynes; Brandon F Keele; Beatrice H Hahn; George M Shaw
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

4.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

Review 5.  HIV transmission.

Authors:  George M Shaw; Eric Hunter
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

Review 6.  Bottlenecks in HIV-1 transmission: insights from the study of founder viruses.

Authors:  Sarah B Joseph; Ronald Swanstrom; Angela D M Kashuba; Myron S Cohen
Journal:  Nat Rev Microbiol       Date:  2015-06-08       Impact factor: 60.633

7.  In-vitro resistance to zidovudine and alpha-interferon in HIV-1 isolates from patients: correlations with treatment duration and response.

Authors:  B R Edlin; M H St Clair; P M Pitha; S M Whaling; D M King; J D Bitran; R A Weinstein
Journal:  Ann Intern Med       Date:  1992-09-15       Impact factor: 25.391

8.  Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing.

Authors:  Jesus F Salazar-Gonzalez; Elizabeth Bailes; Kimmy T Pham; Maria G Salazar; M Brad Guffey; Brandon F Keele; Cynthia A Derdeyn; Paul Farmer; Eric Hunter; Susan Allen; Olivier Manigart; Joseph Mulenga; Jeffrey A Anderson; Ronald Swanstrom; Barton F Haynes; Gayathri S Athreya; Bette T M Korber; Paul M Sharp; George M Shaw; Beatrice H Hahn
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

9.  Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.

Authors:  Jesus F Salazar-Gonzalez; Maria G Salazar; Brandon F Keele; Gerald H Learn; Elena E Giorgi; Hui Li; Julie M Decker; Shuyi Wang; Joshua Baalwa; Matthias H Kraus; Nicholas F Parrish; Katharina S Shaw; M Brad Guffey; Katharine J Bar; Katie L Davis; Christina Ochsenbauer-Jambor; John C Kappes; Michael S Saag; Myron S Cohen; Joseph Mulenga; Cynthia A Derdeyn; Susan Allen; Eric Hunter; Martin Markowitz; Peter Hraber; Alan S Perelson; Tanmoy Bhattacharya; Barton F Haynes; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

Review 10.  Interactions between HIV-1 and the cell-autonomous innate immune system.

Authors:  Greg J Towers; Mahdad Noursadeghi
Journal:  Cell Host Microbe       Date:  2014-07-09       Impact factor: 21.023

View more
  74 in total

1.  Replication Capacity of Viruses from Acute Infection Drives HIV-1 Disease Progression.

Authors:  Philippe Selhorst; Carina Combrinck; Nonkululeko Ndabambi; Sherazaan D Ismail; Melissa-Rose Abrahams; Miguel Lacerda; Natasha Samsunder; Nigel Garrett; Quarraisha Abdool Karim; Salim S Abdool Karim; Carolyn Williamson
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

2.  A Novel Phenotype Links HIV-1 Capsid Stability to cGAS-Mediated DNA Sensing.

Authors:  Mohammad Adnan Siddiqui; Akatsuki Saito; Upul D Halambage; Damien Ferhadian; Douglas K Fischer; Ashwanth C Francis; Gregory B Melikyan; Zandrea Ambrose; Christopher Aiken; Masahiro Yamashita
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

3.  Expanding role for type I Interferons in restricting HIV growth.

Authors:  Stephen J Kent; Anthony D Kelleher
Journal:  Immunol Cell Biol       Date:  2017-04-25       Impact factor: 5.126

Review 4.  HIV-1 Infection and Type 1 Interferon: Navigating Through Uncertain Waters.

Authors:  Sho Sugawara; David L Thomas; Ashwin Balagopal
Journal:  AIDS Res Hum Retroviruses       Date:  2018-08-15       Impact factor: 2.205

5.  Variable infectivity and conserved engagement in cell-to-cell viral transfer by HIV-1 Env from Clade B transmitted founder clones.

Authors:  Hongru Li; Benjamin K Chen
Journal:  Virology       Date:  2018-11-08       Impact factor: 3.616

6.  Reduced Chronic Lymphocyte Activation following Interferon Alpha Blockade during the Acute Phase of Simian Immunodeficiency Virus Infection in Rhesus Macaques.

Authors:  Diane Carnathan; Benton Lawson; Joana Yu; Kalpana Patel; James M Billingsley; Gregory K Tharp; Olivia M Delmas; Reem Dawoud; Peter Wilkinson; Charles Nicolette; Mark J Cameron; Rafick-Pierre Sekaly; Steven E Bosinger; Guido Silvestri; Thomas H Vanderford
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

7.  BST-2 Expression Modulates Small CD4-Mimetic Sensitization of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.

Authors:  Jonathan Richard; Jérémie Prévost; Benjamin von Bredow; Shilei Ding; Nathalie Brassard; Halima Medjahed; Mathieu Coutu; Bruno Melillo; Frédéric Bibollet-Ruche; Beatrice H Hahn; Daniel E Kaufmann; Amos B Smith; Joseph Sodroski; Daniel Sauter; Frank Kirchhoff; Katrina Gee; Stuart J Neil; David T Evans; Andrés Finzi
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

8.  Number of HIV-1 founder variants is determined by the recency of the source partner infection.

Authors:  Ch Julián Villabona-Arenas; Matthew Hall; Katrina A Lythgoe; Stephen G Gaffney; Roland R Regoes; Stéphane Hué; Katherine E Atkins
Journal:  Science       Date:  2020-07-03       Impact factor: 47.728

9.  Interferon-I: The Pièce de Résistance of HIV-1 Transmission?

Authors:  Damien C Tully; Daniel T Claiborne; Todd M Allen
Journal:  Trends Microbiol       Date:  2017-03-09       Impact factor: 17.079

10.  A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis.

Authors:  Stephanie M Dillon; Kejun Guo; Gregory L Austin; Sara Gianella; Phillip A Engen; Ece A Mutlu; John Losurdo; Garth Swanson; Prachi Chakradeo; Ali Keshavarzian; Alan L Landay; Mario L Santiago; Cara C Wilson
Journal:  AIDS       Date:  2018-07-31       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.